574 related articles for article (PubMed ID: 37238686)
1. Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System.
Maiese K
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238686
[TBL] [Abstract][Full Text] [Related]
2. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.
Maiese K
Front Immunol; 2023; 14():1273570. PubMed ID: 38022638
[TBL] [Abstract][Full Text] [Related]
3. The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
Maiese K
Curr Neurovasc Res; 2023; 20(3):314-333. PubMed ID: 37488757
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of metabolic flexibility: The impact of mTOR on autophagy in neurodegenerative disease.
Maiese K
Int Rev Neurobiol; 2020; 155():1-35. PubMed ID: 32854851
[TBL] [Abstract][Full Text] [Related]
5. Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.
Maiese K
Curr Neurovasc Res; 2017; 14(2):184-189. PubMed ID: 28294062
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.
Maiese K
Expert Rev Clin Pharmacol; 2020 Jan; 13(1):23-34. PubMed ID: 31794280
[No Abstract] [Full Text] [Related]
7. Oxidative Stress and Decreased Mitochondrial Superoxide Dismutase 2 and Peroxiredoxins 1 and 4 Based Mechanism of Concurrent Activation of AMPK and mTOR in Alzheimer's Disease.
Majd S; Power JHT
Curr Alzheimer Res; 2018; 15(8):764-776. PubMed ID: 29473507
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes.
Maiese K
Curr Neurovasc Res; 2020; 17(5):765-783. PubMed ID: 33183203
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.
Maiese K
Curr Neurovasc Res; 2021; 18(1):134-149. PubMed ID: 33397266
[TBL] [Abstract][Full Text] [Related]
10. Magnolol improves Alzheimer's disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK/mTOR/ULK1 pathway.
Wang X; Jia J
Biomed Pharmacother; 2023 May; 161():114473. PubMed ID: 36889111
[TBL] [Abstract][Full Text] [Related]
11. New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.
Maiese K
Front Biosci (Landmark Ed); 2020 Jun; 25(11):1925-1973. PubMed ID: 32472766
[TBL] [Abstract][Full Text] [Related]
12. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.
Maiese K
Curr Neurovasc Res; 2017; 14(3):299-304. PubMed ID: 28721811
[TBL] [Abstract][Full Text] [Related]
13. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.
Maiese K
Br J Clin Pharmacol; 2016 Nov; 82(5):1245-1266. PubMed ID: 26469771
[TBL] [Abstract][Full Text] [Related]
14. Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK.
Maiese K
Cells; 2023 Nov; 12(22):. PubMed ID: 37998330
[TBL] [Abstract][Full Text] [Related]
15. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
Di Domenico F; Barone E; Perluigi M; Butterfield DA
Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216
[TBL] [Abstract][Full Text] [Related]
16. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.
Maiese K
Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460
[TBL] [Abstract][Full Text] [Related]
17. Roles of AMP-activated protein kinase in Alzheimer's disease.
Cai Z; Yan LJ; Li K; Quazi SH; Zhao B
Neuromolecular Med; 2012 Mar; 14(1):1-14. PubMed ID: 22367557
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin inhibits activation of AMPK-mTOR signaling pathway-induced Alzheimer's disease lesion in hippocampus of rats with type 2 diabetes mellitus.
Sun Q; Wei LL; Zhang M; Li TX; Yang C; Deng SP; Zeng QC
Int J Neurosci; 2019 Feb; 129(2):179-188. PubMed ID: 29962282
[TBL] [Abstract][Full Text] [Related]
19. AMPK activation does not enhance autophagy in neurons in contrast to MTORC1 inhibition: different impact on β-amyloid clearance.
Benito-Cuesta I; Ordóñez-Gutiérrez L; Wandosell F
Autophagy; 2021 Mar; 17(3):656-671. PubMed ID: 32075509
[TBL] [Abstract][Full Text] [Related]
20. Cognitive Impairment in Multiple Sclerosis.
Maiese K
Bioengineering (Basel); 2023 Jul; 10(7):. PubMed ID: 37508898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
